Enhanced Bedside Microdialysis for TBI
针对 TBI 的增强型床边微透析
基本信息
- 批准号:9981842
- 负责人:
- 金额:$ 53.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsAnti-Inflammatory AgentsBedside TechnologyBiological AssayBlood flowBrainBrain InjuriesCessation of lifeChemicalsChildClinicalDangerousnessDevicesDexamethasoneDiagnosticElectrocorticogramElectrodesElectroencephalographyEpidemicFemaleFluorescence MicroscopyGenderGliosisGlucoseGoalsHospitalizationHypoglycemiaImmunohistochemistryIncidenceInformed ConsentInjuryInstitutional Review BoardsInstitutionalized PersonsIntensive CareIntracranial PressureKnowledgeLaboratoriesLeadLesionLiquid substanceMetabolicMicrodialysisMonitorNeurosciencesNeurosurgeonOperative Surgical ProceduresPatient-Focused OutcomesPatientsPerformancePerfusionPersonsPhysiciansPregnant WomenRaceRattusReportingResearch PersonnelRiskTechnologyTherapeuticTimeTissuesTranslatingTraumatic Brain InjuryVegetative StatesVentriculostomyWireless Technologybrain metabolismbrain tissueclinical translationcontrolled cortical impactdisabilityinjuredinterstitialmalemedically necessary careneurosurgerynew technologypostoperative recoverypre-clinicalpreclinical developmentpreclinical studypressure sensorpreventrecruittemporal measurement
项目摘要
The goal of this project is to deliver enhanced bedside microdialysis for monitoring interstitial brain glucose and K+ levels in patients in intensive care after neurosurgery for severe traumatic brain injury. The ultimate objective is to quantify, in real time, the magnitude and duration of metabolic crises caused by spreading depolarization (SD), which are prevalent in the injured brain and underlie the secondary injury responsible for poor patient outcomes, including severe disability, vegetative state, and death.
Electrocorticography (ECoG) shows that the injured brain is highly susceptible to SD but ECoG is not designed to detect or quantify the impact of SD on brain metabolism. Repolarization of tissues after SD requires such vast amounts of energy that glucose levels can be driven dangerously low, especially in injured tissue where blood flow to resupply glucose may be compromised. By quantifying the magnitude and duration of hypoglycemic episodes in the injury penumbra, we will deliver a diagnostic for secondary injury. The present absence of diagnostic technology is a roadblock to therapeutic strategies for managing secondary injury. Although clinical microdialysis has the demonstrated ability to quantify metabolic crisis after SD, substantial technical enhancements are urgently needed. Patients need to be monitored for 10 days after surgery but, due to gliosis at the probe track, conventional microdialysis is of limited value after 2-3 days. Preclinical studies in the Michael laboratory have demonstrated that retrodialysis of dexamethasone, a potent anti-inflammatory agent, is a simple yet highly effective means of extending functional microdialysis to at least 10 days. Microdialysis will be further enhanced by new technology, developed by the Boutelle group, for continuous, rapid, on-line, wireless, automated assays of glucose and K+ with 1-min temporal resolution. With the aid of expert neurosurgeons, we propose to translate enhanced microdialysis to patients with severe traumatic brain injury, to determine the statistical significance of correlations between chemical recordings and patient outcomes, and to continue the preclinical refinement of our enhanced microdialysis approaches.
该项目的目标是提供增强的床边微透析,以监测严重创伤性脑损伤神经外科手术后重症监护患者的脑间质葡萄糖和 K+ 水平。最终目标是实时量化由扩散去极化 (SD) 引起的代谢危机的严重程度和持续时间,这种情况在受伤的大脑中普遍存在,是导致患者预后不良的继发性损伤的基础,包括严重残疾、植物人状态和死亡。
皮质电图 (ECoG) 显示受伤的大脑对 SD 高度敏感,但 ECoG 的目的并不是检测或量化 SD 对大脑代谢的影响。 SD 后组织的复极化需要大量能量,导致葡萄糖水平可能降至危险的低水平,尤其是在受损组织中,补充葡萄糖的血流可能受到损害。通过量化损伤半暗带中低血糖发作的程度和持续时间,我们将对继发性损伤进行诊断。目前缺乏诊断技术是控制继发性损伤的治疗策略的障碍。尽管临床微透析已被证明能够量化 SD 后的代谢危机,但仍迫切需要实质性的技术改进。手术后需要对患者进行 10 天的监测,但由于探针轨道处有神经胶质增生,传统的微透析在 2-3 天后的价值有限。 Michael 实验室的临床前研究表明,地塞米松(一种有效的抗炎剂)的逆透析是一种简单而高效的方法,可将功能性微透析时间延长至少 10 天。 Boutelle 集团开发的新技术将进一步增强微透析技术,以 1 分钟的时间分辨率连续、快速、在线、无线、自动地检测葡萄糖和 K+。在神经外科医生专家的帮助下,我们建议将增强型微透析应用于严重创伤性脑损伤患者,以确定化学记录与患者结果之间相关性的统计显着性,并继续对增强型微透析方法进行临床前改进。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adrian C Michael其他文献
Adrian C Michael的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adrian C Michael', 18)}}的其他基金
Technical enhancements for intracranial microdialysis
颅内微透析的技术改进
- 批准号:
9789967 - 财政年份:2018
- 资助金额:
$ 53.31万 - 项目类别:
Neuroprotection of Dopamine During Microdialysis
微透析过程中多巴胺的神经保护
- 批准号:
8540509 - 财政年份:2013
- 资助金额:
$ 53.31万 - 项目类别:
Neuroprotection of Dopamine During Microdialysis
微透析过程中多巴胺的神经保护
- 批准号:
8657494 - 财政年份:2013
- 资助金额:
$ 53.31万 - 项目类别:
Ultrastructural Basis of Neurochemical Measures in Brain
大脑神经化学测量的超微结构基础
- 批准号:
7260649 - 财政年份:2007
- 资助金额:
$ 53.31万 - 项目类别:
相似国自然基金
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带森林土壤氮添加下微节肢动物对氮转化过程的调控
- 批准号:32360323
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Slc39a13在哺乳动物铁代谢中的作用
- 批准号:32371226
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
乳酸介导的组蛋白乳酸化调控哺乳动物主要合子基因组激活的机制研究
- 批准号:82301880
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 53.31万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 53.31万 - 项目类别:
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 53.31万 - 项目类别:
Adult human brain tissue cultures to study neuroHIV
成人脑组织培养研究神经艾滋病毒
- 批准号:
10619170 - 财政年份:2023
- 资助金额:
$ 53.31万 - 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 53.31万 - 项目类别: